![](https://cdn.snapi.dev/images/v1/r/n/conf12-1575390.jpg)
News for Vaxart Stock (VXRT)
![](https://cdn.snapi.dev/images/v1/r/n/conf12-1575390.jpg)
The Motley Fool •
![](https://cdn.snapi.dev/images/v1/c/a/cashier-handing-product-to-customer-in-a-store-1567890.jpg)
![](https://cdn.snapi.dev/images/v1/c/l/press12-1527470.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/e/i/conf6-1526937.jpg)
![](https://cdn.snapi.dev/images/v1/u/7/press5-1525868.jpg)
![](https://cdn.snapi.dev/images/v1/i/p/press11-1519949.jpg)
![](https://cdn.snapi.dev/images/v1/w/x/transcript17-1494645.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/n/a/biotech27-1494413.jpg)
![](https://cdn.snapi.dev/images/v1/c/2/press6-1493887.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/d/y/press4-1492779.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/p/r/press15-1490131.jpg)
The Motley Fool •
![](https://cdn.snapi.dev/images/v1/w/6/doctor-points-to-pill-bottle-while-explaining-to-patient-1484124.jpg)
Vaxart to Host Second Quarter 2022 Business Update and Financial Results Conference Call on August 8
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/d/j/conf8-1475540.jpg)
![](https://cdn.snapi.dev/images/v1/s/m/press16-1470697.jpg)
![](https://cdn.snapi.dev/images/v1/c/1/press16-1459875.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/l/p/conf2-1452137.jpg)
![](https://cdn.snapi.dev/images/v1/j/s/press20-1437601.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/h/r/press20-1435832.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/w/1/conf20-1419822.jpg)
The Motley Fool •
![](https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6839022finvestor-sits-on-couch-and-looks-at-laptop-in-consternationjpgw700opresize-1410382.jpg)
![](https://cdn.snapi.dev/images/v1/j/b/press8-1407990.jpg)
The Motley Fool •
![](https://cdn.snapi.dev/images/v1/3/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6834402fnurse-vaccinates-man-while-wearing-ppejpgw700opresize-1406289.jpg)
New Preclinical Data Demonstrate Two of Vaxart's COVID-19 Vaccine Candidates Protect Against Omicron
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/k/t/press11-1402081.jpg)
The Motley Fool •
![](https://cdn.snapi.dev/images/v1/v/i/vitaldata1600-300x169-1400300.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/a/6/press18-1400217.jpg)